Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | METAP2 | P50579 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | NPY1R | P25929 | 1/20 | 0.45 |
| ▸ | NPY2R | P49146 | 1/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL892960 | 0.90 | MMP8 (0.61) | MMP8MEN1KMT2ANPC1L3MBTL1 | |
| SCHEMBL10429976 | 0.88 | MMP8 (0.56) | MMP8MEN1KMT2ANPC1L3MBTL1 | |
| SCHEMBL5143568 | 0.87 | MMP8 (0.55) | MMP8MEN1KMT2ANPC1L3MBTL1 | |
| SCHEMBL13752142 | 0.85 | MMP8 (0.54) | MMP8MEN1KMT2ANPC1L3MBTL1 | |
| SCHEMBL5145270 | 0.85 | MMP8 (0.54) | MMP8MEN1KMT2ANPC1L3MBTL1 | |
| SCHEMBL7420068 | 0.85 | MMP8 (0.54) | MMP8MEN1KMT2ANPC1L3MBTL1 | |
| SCHEMBL3123872 | 0.85 | MMP8 (0.54) | MMP8MEN1KMT2ANPC1L3MBTL1 | |
| SCHEMBL7431774 | 0.85 | KMT2A (0.62) | MEN1KMT2ANPC1L3MBTL1ALDH1A1 | |
| SCHEMBL27622664 | 0.85 | MMP8 (0.56) | MMP8MEN1KMT2ANPC1L3MBTL1 | |
| SCHEMBL15016003 | 0.85 | MMP8 (0.56) | MMP8MEN1KMT2ANPC1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200317674-A1 | PYRAZOLOPYRIMIDINE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME | An2H Discovery Limited (IE) | 2020-10-08 | — | — | US | disclosed |
| EP-1746110-B1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION REACTION AND CATALYST THEREOF | CHINA PETROLEUM & CHEMICAL (CN) | 2015-03-11 | — | — | EP | disclosed |
| US-7351778-B2 | Catalyst component for olefin polymerization and catalyst comprising the same | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2008-04-01 | — | — | US | disclosed |
| EP-1746110-A1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION REACTION AND CATALYST THEREOF | China Petroleum & Chemical Corporation (CN) | 2007-01-24 | — | — | EP | disclosed |
| US-20060287446-A1 | Catalyst component for olefin polymerization and catalyst comprising the same | BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY CHINA PETROLEUM & CHEMICAL COPORATION (CN) | 2006-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200317674-A1 | PYRAZOLOPYRIMIDINE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME | PINK1, ADRM1, LRRK2 | MMP8 2965/4885MEN1 4725/4885KMT2A 2432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.